Frequent pathologic complete responses in aggressive stages II to III breast cancers with every-4-week carboplatin and weekly paclitaxel with or without trastuzumab: a Brown University Oncology Group Study (Q33386059)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Frequent pathologic complete responses in aggressive stages II to III breast cancers with every-4-week carboplatin and weekly paclitaxel with or without trastuzumab: a Brown University Oncology Group Study
scientific article

    Statements

    Frequent pathologic complete responses in aggressive stages II to III breast cancers with every-4-week carboplatin and weekly paclitaxel with or without trastuzumab: a Brown University Oncology Group Study (English)
    William M Sikov
    Rochelle Strenger
    Robert D Legare
    Kathy P Theall
    Theresa A Graves
    Jennifer S Gass
    Teresa A Kennedy
    Mary Anne Fenton
    4693-4700

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit